Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovation Asset Collective (IAC) is a Canadian not-for-profit, membership-based organization established in 2019 and funded by the Government of Canada. Its mission is to help small and medium-sized enterprises (SMEs) in the data-driven cleantech sector develop, protect, and leverage intellectual property (IP) strategies. IAC provides education, strategic counsel, patent generation support, prior art research, and access to a defensive patent portfolio. The organization does not develop therapeutics or healthcare products but instead focuses on empowering Canadian innovators to retain ownership of their IP assets and compete globally[1][2][3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovation Asset Collective.